Senior Scientist Clinical Pharmacology, Modeling & Simulation - San Francisco, CA | Biospace
Get Our FREE Industry eNewsletter

Senior Scientist Clinical Pharmacology, Modeling & Simulation

Amgen

Apply
Location:
San Francisco, CA
Posted Date:
12/4/2016
Position Type:
Full time
Job Code:
R-29380
Salary:
Required Education:
Bachelors Degree
Areas of Expertise Desired:

Job Description

Amgen is seeking a highly motivated and team-oriented  Senior Scientist in the Clinical Pharmacology, Modeling and Simulation (CPMS) Department.

The Senior Scientist will serve as a PK/PD analyst and Pharmacometrican to support Amgen Development and Discovery programs across Therapeutic Areas. The Senior Scientist will participate on cross-functional compound development project teams and will be responsible for the application of modeling and simulation (M&S) to characterize PK/PD for small and large molecules.

Responsible for hands-on PK/PD analyses and simulations, report writing, and participate in the summary documents for regulatory submissions.

Requirements

Basic Qualifications:

Doctorate degree and 2 years PK/PD experience OR

Master's degree and 5 years of PK/PD experience OR

Bachelor's degree and 7 years of PK/PD experience

Preferred Qualifications:

PhD in Pharmacokinetics, Pharmaceutical Sciences, Engineering, or related fields with equivalent professional degrees (e.g. MD, PharmD) and 3+ years of experience in the Biotechnology/Pharmaceutical Industry, consulting or post-doctoral training

Expertise in PK/PD modeling and population-based analyses/simulations with established track-record records of model-based drug development

Experience in supporting preclinical/clinical PK, PK/PD, and modeling & simulation components of regulatory documentations

Excellent interpersonal, technical, and communication skills to lead cross-functional teams

Demonstrated experience with modeling and simulation software (e.g. NONMEM, SAS, S-Plus, R, Phoenix, MATLAB and / or Clinical Trial Simulator)

Previous record of scientific contributions through peer-reviewed articles and external presentations

Amgen focuses on areas of high, unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.